Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-metastatic effects of 2,4,7-trisubstituted pyrimidoindole compounds

A compound and composition technology, applied in 2 fields, can solve problems such as family and social influence

Active Publication Date: 2022-04-19
GUANGDONG MEDICAL UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This not only causes a serious economic burden to patients, but also has a major impact on families and society.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-metastatic effects of 2,4,7-trisubstituted pyrimidoindole compounds
  • Anti-metastatic effects of 2,4,7-trisubstituted pyrimidoindole compounds
  • Anti-metastatic effects of 2,4,7-trisubstituted pyrimidoindole compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0030] In one aspect, the present invention provides the compound 2-benzyl-4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-ethylamino)-7-(2- Methyltetrazol-5-yl)pyrimidin[4,5]indole, or an isomer, prodrug, pharmaceutically acceptable salt or solvate thereof.

[0031] Its structure is shown in the following formula:

[0032]

[0033] In one aspect, the invention provides a compound selected from any subset list of compounds within the scope of the exemplary embodiments, or an isomer, prodrug, pharmaceutically acceptable salt or solvate thereof.

[0034] III. Other embodiments of the present invention

[0035] In another embodiment, the present invention provides a pharmaceutical composition comprising at least one compound of the present invention or a process for the preparation of an isomer, prodrug, pharmaceutically acceptable salt or solvate thereof, Include the following steps:

1)

[0036]

2)

[0037]

3)

[0038]

4)

[0039]

5)

[0040]

6)...

Embodiment 1

[0062]Example 1: 2-benzyl-4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-ethylamino)-7-(2-methyl tetrazo Synthesis of Azol-5-yl)pyrimidin[4,5]indole (XH003)

[0063] 1.1 Synthesis of 5-(3-nitrophenyl)tetrazolium (B001)

[0064]

[0065] Take 30.0g (202.69mmol) of m-nitrobenzonitrile, 14.5g (222.96mmol) of sodium azide, and 45.7g (202.69mol) of zinc bromide in a 1000ml flask, add 500ml of water, reflux at 100°C for 24h, then cool down To room temperature, pour the reaction solution into 500ml of water, add 100ml of 3N hydrochloric acid, extract with ethyl acetate (3×200ml), collect the organic phase, spin dry the ethyl acetate under reduced pressure to obtain a white solid, add 800ml of 0.25mol / L NaOH, stirred, the solid dissolved first and then re-precipitated white flocculent zinc hydroxide, suction filtered, the filtrate was adjusted to pH=5 with 3.0mol / L hydrochloric acid, a large amount of white solid was precipitated, and the dry white product was 34.8g, the yield ...

Embodiment 2

[0099] Example 2: Effect of Compound XH003 on Migration Experiment of Breast Cancer MCF-7 Cells

[0100] Take MCF-7 cells in the logarithmic growth phase, wash away dead cells and dead cell debris with PBS, digest with 0.25% trypsin and blow into single cells, trypsinize and centrifuge, use serum-free DMEM medium to adjust cell density 2.5×10 5 cells / ml, 100 μl of the counted cell suspension was added to the Transwell chamber for culture, and then XH003 (1 μM, 2.5 μM, 5 μM), 5 μM cisplatin (positive control group), and complete medium (blank control group) were added respectively. Add 500 μl complete medium containing 10% FBS to the lower chamber of the 24-well plate. After 48 hours, take out the small chamber and suck up the medium, wash the small chamber twice with PBS, fix in 4% paraformaldehyde for 30 minutes, stain with 0.1% crystal violet for 20 minutes, wipe off Matrigel and cells in the upper chamber with a cotton swab, and wash three times with PBS , using an invert...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound with a 2,4,7-trisubstituted pyrimidoindole structure, which can inhibit tumor cell migration and invasion at a very low concentration, and its effect is better than that of cisplatin, a commonly used clinical drug. In addition, the compound of the present invention can also inhibit the expression of matrix metalloproteinase-related proteins that play an important role in the process of tumor migration and invasion. The present invention also relates to the preparation method of this kind of compound, and its application in the aspects of tumor marking, diagnosis, prevention and treatment or adjuvant treatment.

Description

technical field [0001] The invention relates to a 2,4,7-trisubstituted pyrimidoindole compound, its preparation method and its application in anti-tumor metastasis. Background technique [0002] Cancer is a major disease that seriously threatens human health, and about 90% of cancer-related deaths are mainly due to tumor metastasis. Tumor metastasis mainly refers to the process in which malignant tumor cells detach from the primary site and transfer to secondary tissues or organs through direct spread, hematogenous metastasis, lymphatic metastasis, etc., continue to grow and proliferate, and form secondary tumors. This is a multi-step, multi-stage and multi-factor process. Tumor metastasis is the most common cause of death in cancer patients, and it is also a major problem in clinical cancer treatment. [0003] Breast cancer is currently one of the malignant tumors with the highest morbidity and mortality among women, and its incidence ranks first in the incidence of femal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D487/04A61K31/519A61P35/04
CPCC07D487/04A61P35/04
Inventor 徐道华黄云生李玉运谢晓阳
Owner GUANGDONG MEDICAL UNIV